找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Nanoparticle-Mediated Immunotherapy; Tuan Vo-Dinh Book 2021 Springer Nature Switzerland AG 2021 multifunction nanoparticles in medicine.ca

[复制链接]
楼主: 味觉没有
发表于 2025-3-25 04:23:23 | 显示全部楼层
Development of Nanoparticles as a Vaccine Platform. In recent years, due to climate and environmental changes, inoculation against various infectious diseases has become increasingly important. When purified proteins or peptides are used as an antigen for inoculation, the effectiveness of the vaccination is often insufficient. To strengthen the imm
发表于 2025-3-25 08:25:09 | 显示全部楼层
发表于 2025-3-25 14:31:24 | 显示全部楼层
发表于 2025-3-25 19:02:12 | 显示全部楼层
Bioanalysishttp://image.papertrans.cn/n/image/660861.jpg
发表于 2025-3-25 21:35:55 | 显示全部楼层
https://doi.org/10.1007/978-3-030-78338-9multifunction nanoparticles in medicine; cancer nanotechnology; nanoparticle cancer treatment; nanomedi
发表于 2025-3-26 00:51:53 | 显示全部楼层
发表于 2025-3-26 07:01:55 | 显示全部楼层
Nanoparticle-Mediated Immunotherapy978-3-030-78338-9Series ISSN 2364-1118 Series E-ISSN 2364-1126
发表于 2025-3-26 10:02:28 | 显示全部楼层
2364-1118 ls, and systems design.Focuses on clinical potential and tra.This book is intended to serve as an authoritative reference source for a broad audience involved in the research, teaching, learning, and practice of nanotechnology in immunotherapy. The combination of nanotechnology and immunotherapy is
发表于 2025-3-26 12:47:48 | 显示全部楼层
Multifunctional Gold Nanostars for Sensitive Detection, Photothermal Treatment and Immunotherapy of i-cancer immune response, “Cancer Vaccine” effect, to prevent cancer recurrence. Therefore, the biocompatible GNS nanoparticles have the promise for future clinical translation to improve brain cancer diagnostics and therapeutics.
发表于 2025-3-26 17:18:44 | 显示全部楼层
Immunotherapy: From Discovery to Bedsides for new treatments in the immune-oncology space. Herein we review the broad categories of immunotherapy, as well as discuss the pathway(s) for bringing promising treatments to the clinic. Challenges posed by immune-oncology therapies have led to shifts in approaches to clinical trials and we will discuss these as well.
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-2 06:17
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表